Publications
- The outcome of chronic lymphocytic leukemia patients who relapsed after fludarabine, cyclophosphamide, and rituximab2013 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Assessment of selected markers of apoptosis and angiogenesis in chronic lymphocytic leukemia2013 | Faculty of Medicine in Hradec Králové
- Rituximab in combination with high-dose dexamethasone for the treatment of relapsed/refractory chronic lymphocytic leukemia2012 | Faculty of Medicine in Hradec Králové
- Our experience with the treatment of primary lymphomas of the central nervous system2012 | Faculty of Medicine in Hradec Králové
- Primary central nervous system lymphomas2010 | Faculty of Medicine in Hradec Králové
- Chronic lymphocytic leukemia2010 | Faculty of Medicine in Hradec Králové
- Primary central nervous system lymphoma +12009 | Faculty of Medicine in Hradec Králové
- Addition of rituximab significantly improves outcomes in patients with diffuse large B-cell lymphoma a single-center, retrospective study2007 | Faculty of Medicine in Hradec Králové
- Treatment of essential thrombocytemia in pregnancy the case report2006 | Faculty of Medicine in Hradec Králové
- Successfulmabcampathem treatment in patient with Sezary´s syndrom at prophylactic valganciklovirus therapy +1Publication without faculty affiliation
Loading network view...